Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Sharp

Showing results (51-60 of 105) with videos related to

Pageof 11
Sort By:
Circulation. Cardiovascular Interventions|June 3, 2020
Are Higher Operator Volumes for Unprotected Left Main Stem Percutaneous Coronary Intervention Associated With Improved Patient Outcomes?: A Survival Analysis of 6724 Procedures From the British Cardiovascular Intervention Society National DatabaseTim Kinnaird, Sean Gallagher, Richard Anderson, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 13, 2025
Placental Growth Factor Led Management of the Small for Gestational Age Fetus: Randomised Controlled Feasibility StudySiân Bullough, Michelle Dower, Richard Jackson, et al.
British Journal of Clinical Pharmacology|September 7, 2016
Spontaneous adverse drug reaction reports for neonates and infants in the UK 2001-2010: content and utility analysisDaniel B Hawcutt, Nicki-Jayne Russell, Hannah Maqsood, et al.
Acta Obstetricia Et Gynecologica Scandinavica|February 5, 2020
Diagnostic accuracy of repeat placental growth factor measurements in women with suspected preeclampsia: A case series studyKate E Duhig, Louise M Webster, Andrew Sharp, et al.
Antimicrobial Agents and Chemotherapy|November 8, 2006
Effect of neutropenia and treatment delay on the response to antifungal agents in experimental disseminated candidiasisWilliam W Hope, George L Drusano, Caroline B Moore, et al.
Antimicrobial Agents and Chemotherapy|September 7, 2006
Derivation of an in vivo drug exposure breakpoint for flucytosine against Candida albicans and Impact of the MIC, growth rate, and resistance genotype on the antifungal effectWilliam W Hope, Peter A Warn, Andrew Sharp, et al.
Antimicrobial Agents and Chemotherapy|August 3, 2011
Pharmacodynamics of echinocandins against Candida glabrata: requirement for dosage escalation to achieve maximal antifungal activity in neutropenic hostsSusan J Howard, Joanne Livermore, Andrew Sharp, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2007
Optimization of the dosage of flucytosine in combination with amphotericin B for disseminated candidiasis: a pharmacodynamic rationale for reduced dosingWilliam W Hope, Peter A Warn, Andrew Sharp, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|August 18, 2010
Placental viral infection sensitizes to endotoxin-induced pre-term labor: a double hit hypothesisIngrid Cardenas, Gil Mor, Paulomi Aldo, et al.
The Journal of Infectious Diseases|March 2, 2011
Pharmacokinetics and pharmacodynamics of posaconazole for invasive pulmonary aspergillosis: clinical implications for antifungal therapySusan J Howard, Jodi M Lestner, Andrew Sharp, et al.
Pageof 11

Showing results (51-60 of 105) with videos related to

Sort By:
Pageof 11
Circulation. Cardiovascular Interventions|June 3, 2020
Are Higher Operator Volumes for Unprotected Left Main Stem Percutaneous Coronary Intervention Associated With Improved Patient Outcomes?: A Survival Analysis of 6724 Procedures From the British Cardiovascular Intervention Society National DatabaseTim Kinnaird, Sean Gallagher, Richard Anderson, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 13, 2025
Placental Growth Factor Led Management of the Small for Gestational Age Fetus: Randomised Controlled Feasibility StudySiân Bullough, Michelle Dower, Richard Jackson, et al.
British Journal of Clinical Pharmacology|September 7, 2016
Spontaneous adverse drug reaction reports for neonates and infants in the UK 2001-2010: content and utility analysisDaniel B Hawcutt, Nicki-Jayne Russell, Hannah Maqsood, et al.
Acta Obstetricia Et Gynecologica Scandinavica|February 5, 2020
Diagnostic accuracy of repeat placental growth factor measurements in women with suspected preeclampsia: A case series studyKate E Duhig, Louise M Webster, Andrew Sharp, et al.
Antimicrobial Agents and Chemotherapy|November 8, 2006
Effect of neutropenia and treatment delay on the response to antifungal agents in experimental disseminated candidiasisWilliam W Hope, George L Drusano, Caroline B Moore, et al.
Antimicrobial Agents and Chemotherapy|September 7, 2006
Derivation of an in vivo drug exposure breakpoint for flucytosine against Candida albicans and Impact of the MIC, growth rate, and resistance genotype on the antifungal effectWilliam W Hope, Peter A Warn, Andrew Sharp, et al.
Antimicrobial Agents and Chemotherapy|August 3, 2011
Pharmacodynamics of echinocandins against Candida glabrata: requirement for dosage escalation to achieve maximal antifungal activity in neutropenic hostsSusan J Howard, Joanne Livermore, Andrew Sharp, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2007
Optimization of the dosage of flucytosine in combination with amphotericin B for disseminated candidiasis: a pharmacodynamic rationale for reduced dosingWilliam W Hope, Peter A Warn, Andrew Sharp, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|August 18, 2010
Placental viral infection sensitizes to endotoxin-induced pre-term labor: a double hit hypothesisIngrid Cardenas, Gil Mor, Paulomi Aldo, et al.
The Journal of Infectious Diseases|March 2, 2011
Pharmacokinetics and pharmacodynamics of posaconazole for invasive pulmonary aspergillosis: clinical implications for antifungal therapySusan J Howard, Jodi M Lestner, Andrew Sharp, et al.
Pageof 11